E
Elena Nikiphorou
Researcher at King's College London
Publications - 263
Citations - 3444
Elena Nikiphorou is an academic researcher from King's College London. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 24, co-authored 172 publications receiving 1849 citations. Previous affiliations of Elena Nikiphorou include Leiden University Medical Center & New Cross Hospital.
Papers
More filters
Journal ArticleDOI
Sat0676 supporting early career researchers in rheumatology and musculoskeletal medicine: results from an emerging eular network (emeunet) survey
Meghna Jani,Alexandre Sepriano,Marloes van Onna,Katie L Druce,Anne Troldborg,Aurélie Najm,Alessia Alunno,Elena Nikiphorou +7 more
TL;DR: A large proportion of ECRs in rheumatology felt they lack resources to develop their research skills locally, so small grant funding, research opportunities for pan-European collaborations, short periods of exchange to other institutes and targeted support to develop research skills can help address some of the current needs of E CRs.
Journal ArticleDOI
Intra-articular therapies: patient preferences and professional practices in European countries.
Jenny de la Torre-Aboki,Jacqueline Uson,Irene A Pitsillidou,V. Vardanyan,Elena Nikiphorou,Sebastian C. Rodriguez-García,Raul Castellanos-Moreira,Hemant Pandit,Terence W O'Neill,Michael Doherty,Mikael Boesen,Ingrid Möller,Lene Terslev,Maria Antonietta D'Agostino,W. U. Kampen,Francis Berenbaum,Esperanza Naredo,Loreto Carmona +17 more
TL;DR: The most frequent indications for IAT are arthritis (76%), osteoarthritis (74%), crystal arthritis (71%) and bursitis (70%), the most frequently injected joints are knee (78%), and shoulder (70%); and the most used compounds are glucocorticoids as mentioned in this paper.
Journal ArticleDOI
An improved understanding of sex and gender is crucial for precision rheumatology
Helena Marzo-Ortega,Victoria Navarro-Compán,Servet Akar,Uta Kiltz,Zoe Clark,Elena Nikiphorou +5 more
TL;DR: It is strongly believed that female patient inclusion in clinical trials needs to be encouraged in order to address significant gaps in the authors' knowledge, not only in the field of axSpA but also in other disease areas.
Proceedings ArticleDOI
Thu0642 eular points to consider for the development, evaluation and implementation of mobile health applications for self-management in patients with rheumatic and musculoskeletal diseases
Aurélie Najm,Elena Nikiphorou,Marie Kostine,Christophe Richez,John D Pauling,Axel Finckh,Valentin Ritschl,Yeliz Prior,Petra Balazova,Simon Stones,Zoltán Szekanecz,Annamaria Iagnocco,Sofia Ramiro,Francisca Sivera,Maxime Dougados,Loreto Carmona,Gerd R Burmester,Laure Gossec,Francis Berenbaum +18 more
TL;DR: This EULAR task force established points to consider (PtC) on important aspects that should be considered for the development of new apps, the quality assessment of existing apps, as well as for further development of existingapps.